19.07.2017
- The US Food and Drug Administration (FDA) has approved Nerlynx (neratinib), made by Puma Biotechnology for the extended adjuvant treatment of early-stage, HER2-positive breast...
12.07.2017
- The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...
10.07.2017
- UK drugmaker GlaxoSmithKline (GSK) is to collaborate with artificial intelligence (AI) company Exscientia. The partnership will see Exscientia combine its AI-enabled platform with...
05.07.2017
- Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...
16.06.2017
- US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...
12.06.2017
- UK biotech Glythera has launched a project to develop next-generation antibody drug conjugates (ADCs) for difficult-to-treat tumors, backed by funding of £1 million from government...
09.05.2017
- US healthcare giant Johnson & Johnson (J&J) has said it will appeal the verdict of a jury in St. Louis, Missouri, ordering the company to pay more than $110 million in damages to a...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
